Journal of Chromatography B 2010-01-01

Simultaneous determination ofm-nisoldipine and its three metabolites in rat plasma by liquid chromatography–mass spectrometry

Dezhi Kong, Sanni Li, Xiaowei Zhang, Jianmin Gu, Man Liu, Yan Meng, Yan Fu, Xiaojin La, Gangqiang Xue, Lantong Zhang, Qiao Wang, Dezhi Kong, Sanni Li, Xiaowei Zhang, Jianmin Gu, Man Liu, Yan Meng, Yan Fu, Xiaojin La, Gangqiang Xue, Lantong Zhang, Qiao Wang

Index: J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 878(29) , 2989-96, (2010)

Full Text: HTML

Abstract

A simple, sensitive and selective liquid chromatography–tandem mass spectrometry (LC–MS/MS) method for the simultaneous determination of m-nisoldipine and its three metabolites in rat plasma has been developed using nitrendipine as an internal standard (IS). Following liquid–liquid extraction, the analytes were separated using an isocratic mobile phase on a reverse phase C 18 column and analyzed by MS in the multiple reaction monitoring (MRM) mode. To avoid contamination by residual sample in the injection syringe, a special injection protocol was developed. We found that m-nisoldipine, metabolite M1 and IS could be ionized under positive or negative electrospray ionization conditions, whereas metabolite M and M2 could only be ionized in the positive mode. The mass spectrometry fragmentation pathways for these analytes are analyzed and discussed herein. The total analysis time required less than 5 min per sample. We employed this method successfully to study the metabolism of m-nisoldipine when it was orally administered to rats at a dose of 9 mg/kg. Three metabolites of m-nisoldipine and an unknown compound of molecular weight 386 were found for the first time in rat plasma. The concentration of the potentially active metabolite was approximately equal to its parent compound concentration.


Related Compounds

  • Nisoldipine

Related Articles:

Fast disintegrating tablets of nisoldipine for intra-oral administration.

2014-09-01

[Pharm. Dev. Technol. 19(6) , 641-50, (2014)]

Anti-arrhythmic and hemodynamic effects of oxy nifedipine, oxy nimodipine, oxy nitrendipine and oxy nisoldipine.

2012-10-01

[Pharmacol. Res. 66(4) , 300-8, (2012)]

Why is nisoldipine a specific agent in ischemic left ventricular dysfunction?

1995-04-27

[Am. J. Cardiol. 75(13) , 36E-40E, (1995)]

Adenoviral-mediated expression of dihydropyridine-insensitive L-type calcium channels in cardiac ventricular myocytes and fibroblasts.

2007-06-22

[Eur. J. Pharmacol. 565(1-3) , 7-16, (2007)]

Nisoldipine: a new dihydropyridine calcium-channel blocker.

1993-01-01

[J. Clin. Pharmacol. 33(1) , 46-52, (1993)]

More Articles...